Hepion Pharmaceuticals (NASDAQ:HEPA) Shares Down 4.1% – Time to Sell?
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Free Report) shares dropped 4.1% on Tuesday . The stock traded as low as $0.60 and last traded at $0.60. Approximately 24,048 shares were traded during trading, a decline of 7% from the average daily volume of 25,744 shares. The stock had previously closed at $0.63. Hepion Pharmaceuticals Stock […]
More Stories
Playtika Holding Corp. (NASDAQ:PLTK) Given Consensus Rating of “Hold” by Analysts
Playtika Holding Corp. (NASDAQ:PLTK – Get Free Report) has earned an average rating of “Hold” from the ten research firms...
Softchoice Co. (TSE:SFTC) Receives C$22.67 Consensus PT from Brokerages
Softchoice Co. (TSE:SFTC – Get Free Report) has received a consensus rating of “Hold” from the two analysts that are...
Brokerages Set Verastem, Inc. (NASDAQ:VSTM) Price Target at $13.00
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given an average rating of “Buy” by the nine brokerages that...
Snowflake (NYSE:SNOW) Price Target Raised to $208.00
Snowflake (NYSE:SNOW – Free Report) had its target price boosted by Piper Sandler from $185.00 to $208.00 in a research...
Truist Financial Cuts Ball (NYSE:BALL) Price Target to $73.00
Ball (NYSE:BALL – Free Report) had its price objective decreased by Truist Financial from $78.00 to $73.00 in a report...
Bank of America Cuts Neumora Therapeutics (NASDAQ:NMRA) Price Target to $7.00
Neumora Therapeutics (NASDAQ:NMRA – Free Report) had its price target reduced by Bank of America from $22.00 to $7.00 in...